infohep news

• Sofosbuvir + ribavirin cures hepatitis C for more than 80% of people with HIV and HCV co-infection

  Liz Highleyman / 28 July 2014

  An interferon-free regimen of sofosbuvir (Sovaldi) plus ribavirin for 24 weeks led to sustained hepatitis C virological response in 84 to 89% of HIV-positive people with chronic hepatitis C genotypes 1, 2, ...

• Interferon-free regimens

  AbbVie 3D regimen cures most genotype 1 HCV in people with HIV and HCV co-infection

  Liz Highleyman / 28 July 2014

  An oral regimen of three direct-acting antivirals plus ribavirin taken for 12 weeks demonstrated a sustained virological response rate of 94% for people with both HIV and genotype 1 hepatitis C co-infection ...

• Treatment for people who use drugs

  Interferon-free hepatitis C treatment works for people on methadone or buprenorphine

  Liz Highleyman / 28 July 2014

  People with chronic hepatitis C who are using methadone or buprenorphine to manage opiate addiction can be safely and effectively treated with AbbVie's 3D all-oral direct-acting antiviral regimen plus ribavirin, resulting in a ...

• Finance, funding & health economics

  HCV is a major reason for healthcare utilisation in the United States

  Michael Carter / 24 June 2014

  People with hepatitis C virus (HCV) infection are significant users of healthcare services in the United States, according to research published in the online edition of Clinical Infectious Diseases. Between 2001 and 2010, ...

• Finance, funding & health economics

  Low uptake of HCV treatment in England will lead to substantial disease burden by 2035

  Michael Carter / 24 June 2014

  Only 3% of people with chronic hepatitis C virus (HCV) are treated for their infection each year in England, according to research published in the Journal of Hepatology. The current uptake of ...